SandboxAQ and Mayo Clinic Partner to Revolutionize Cardiac Diagnostics with AI-Powered Magnetocardiography

Collaboration Announcement:
SandboxAQ and Mayo Clinic have announced a collaboration to explore the use of advanced, AI-powered magnetocardiography (MCG) technology for cardiac diagnostics.

Technology Focus:
The collaboration will focus on testing SandboxAQ’s novel MCG imaging system, CardiAQ, which uses magnetic sensors and AI algorithms for non-invasive, non-contact cardiac imaging.

Clinical Research Study:
The initial phase will involve a clinical research study at Mayo Clinic in Rochester, MN, to examine the relationship between MCG and angiography findings throughout 2024 and 2025.

Potential Benefits:
CardiAQ aims to provide faster, more accurate, and accessible medical imaging, filling the gap between low-cost EKG or biomarker tests and high-cost CT scans or invasive angiography.

Advanced Sensors and AI:
The system leverages high-performance sensors to measure minute variations in the magnetic field around the heart and advanced AI algorithms to eliminate electromagnetic interference.

Previous Successes:
Successful clinical studies have already been conducted at UCSF Medical Center and New York’s Mount Sinai West medical center.

Company Background:
SandboxAQ emerged from Alphabet Inc. in 2022 and is backed by leading investors including T. Rowe Price, Eric Schmidt, and Marc Benioff.